Axonics Modulation Technologies, Inc. (AXNX) financial statements (2021 and earlier)

Company profile

Business Address 26 TECHNOLOGY DRIVE
IRVINE, CA 92618
State of Incorp. DE
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments241184158
Cash and cash equivalents24117198
Short-term investments 1359
Receivables1880
Inventory, net of allowances, customer advances and progress billings63164
Inventory63164
Other undisclosed current assets544
Total current assets:328212165
Noncurrent Assets
Property, plant and equipment633
Intangible assets, net (including goodwill)000
Intangible assets, net (excluding goodwill)000
Other noncurrent assets853
Total noncurrent assets:1487
TOTAL ASSETS:342220172
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities23115
Accounts payable1163
Accrued liabilities722
Employee-related liabilities63 
Debt211 
Other undisclosed current liabilities1 1
Total current liabilities:46126
Noncurrent Liabilities
Long-term debt and lease obligation92519
Long-term debt, excluding current maturities 2019
Operating lease, liability94
Other undisclosed noncurrent liabilities(9) 3
Total noncurrent liabilities:92523
Total liabilities:553729
Stockholders' equity
Stockholders' equity attributable to parent287183143
Common stock000
Additional paid in capital522363243
Accumulated other comprehensive loss(0)(0)(0)
Accumulated deficit(234)(180)(100)
Total stockholders' equity:287183143
TOTAL LIABILITIES AND EQUITY:342220172

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
Revenues112141
Cost of revenue
(Cost of Goods and Services Sold)
(44)(6)(0)
Gross profit:6770
Operating expenses(121)(88)(32)
Operating loss:(54)(81)(32)
Nonoperating income (expense)(1)1(0)
Investment income, nonoperating131
Other nonoperating expense(2)(2)(1)
Interest and debt expense(1)(1)(0)
Loss from continuing operations before equity method investments, income taxes:(56)(81)(33)
Other undisclosed income from continuing operations before income taxes110
Loss from continuing operations before income taxes:(55)(80)(32)
Income tax expense(0)(0)(0)
Net loss available to common stockholders, diluted:(55)(80)(32)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
Net loss:(55)(80)(32)
Comprehensive loss:(55)(80)(32)
Other undisclosed comprehensive loss, net of tax, attributable to parent(0)(0)(0)
Comprehensive loss, net of tax, attributable to parent:(55)(80)(32)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: